|
|
|
|
Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma
Qualman S et al.- The incidence of anaplasia in patients with rhabdomyosarcoma is higher than previously described and may be of prognostic significance in children with intermediate-risk embryonal rhabdomyosarcoma.
|
|
|
Boy battles rare cancer
OELWEIN - While most kid are starting to look forward to holiday breaks and presents under the tree, an Oelwein fourth grader is recovering from an operation where a major part of his left leg was removed, is currently in the middle of a...
|
|
|
New rhabdomyosarcoma findings from National Cancer Institute published
'Insulin-like growth factor I receptor (IGF-IR) and its ligands are overexpressed by tumors, mediating proliferation and protecting against stress-induced apoptosis.Accordingly, there has been a considerable amount of interest in...
|
|
|
Bangkok Hospital Ahead of US, UK Hospitals In Cancer Treatment Options
Bangkok Hospital is now ahead of some US and UK hospitals in its options for cancer treatment, with the addition of a new high-tech piece of radiotherapy equipment.Bangkok, Thailand (PRWEB) November 15, 2008 -- Bangkok Hospital recently...
|
|
|
Bangkok Hospital Ahead of US, UK Hospitals In Cancer Treatment Options
Bangkok Hospital is now ahead of some US and UK hospitals in its options for cancer treatment, with the addition of a new high-tech piece of radiotherapy equipment.Bangkok, Thailand (NetSweets) November 15, 2008 Bangkok Hospital recently...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
announced today that a poster presentation authored by Dr.Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of REOLYSIN Inhibits Growth of Human Sarcoma Xenografts Alone and in Combination...
|
|
|
Bangkok Hospital Ahead of US, UK Hospitals In Cancer Treatment Options
Bangkok Hospital recently acquired an IMRT machine, the latest and most popular tool for cancer treatment in the West.The acquisition puts it ahead of major hospitals in the UK and US, many of which are still to acquire the technology.
|
|
|
Oncolytics Biotech Inc. Collaborators to Present Reolysin Research at CTOS Annual Meeting
/PRNewswire-FirstCall/ - Oncolytics Biotech Inc.announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of REOLYSIN Inhibits Growth of...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /CNW/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of REOLYSIN...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of REOLYSIN...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of REOLYSIN...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
In the study, mice were engrafted with a variety of sarcoma cell lines including rhabdomyosarcoma, Ewing's sarcoma, synovial sarcoma and osteosarcoma, then treated with REOLYSIN(R) or REOLYSIN(R) in combination with either cisplatin or...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
In the study, mice were engrafted with a variety of sarcoma cell lines including rhabdomyosarcoma, Ewing's sarcoma, synovial sarcoma and osteosarcoma, then treated with REOLYSIN(R) or REOLYSIN(R) in combination with either cisplatin or...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 Oncolytics-Present CALGARY, Nov. 14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /CNW/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
/PRNewswire-FirstCall via COMTEX/ -- Oncolytics Biotech Inc.(CA:ONC: news, chart, profile) (ONCY: ONCY News, chart, profile, more Last: Delayed quote data Add to portfolio Analyst Create alert Insider Discuss Financials Sponsored by: , , ...
|
